BELLEVUE GROUP AG – Neurocrine Biosciences, Inc. Transaction History
BELLEVUE GROUP AG portfolio value:
$303.24M
portfolio value
BELLEVUE GROUP AG quarter portfolio value change:
+8.96%
quarter
Neurocrine Biosciences, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +0.38% | 10.84K shares | 25.98M | $106.21 | 2.85M |
| Q2 2022 | share | Decrease | -5.93% | -179.14K shares | -6.18M | $97.48 | 2.84M |
| Q1 2022 | share | Decrease | -4.94% | -157.1K shares | 12.56M | $93.75 | 3.02M |
| Q4 2021 | share | Increase | +5.88% | 176.5K shares | -17.23M | $84.63 | 3.18M |
| Q3 2021 | share | Decrease | -0.45% | -13.7K shares | -5.56M | $95.91 | 3.00M |
| Q2 2021 | share | Decrease | -7.84% | -256.8K shares | -24.76M | $97.32 | 3.01M |
| Q1 2021 | share | Decrease | -3.59% | -122.1K shares | -7.11M | $97.25 | 3.27M |
| Q4 2020 | share | Increase | +3.01% | 99.2K shares | 8.48M | $95.85 | 3.39M |
| Q3 2020 | share | Increase | +2.70% | 86.55K shares | -74.64M | $96.16 | 3.29M |
| Q2 2020 | share | Decrease | -1.49% | -48.57K shares | 109.62M | $122 | 3.21M |
| Q1 2020 | share | Decrease | -1.77% | -58.9K shares | -74.58M | $86.55 | 3.25M |
| Q4 2019 | share | Increase | +0.60% | 19.9K shares | 59.46M | $107.49 | 3.31M |
| Q3 2019 | share | Decrease | -6.99% | -247.97K shares | -2.20M | $90.11 | 3.29M |
| Q2 2019 | share | Increase | +17456.65% | 3.52M shares | 297.64M | $84.43 | 3.54M |
| Q1 2019 | share | Decrease | -49.56% | -19.85K shares | -1.08M | $88.1 | 20.2K |
| Q4 2018 | share | Decrease | -3.61% | -1.5K shares | -2.24M | $71.41 | 40.05K |
| Q3 2018 | share | Decrease | -4.59% | -2K shares | 831K | $122.95 | 41.55K |
| Q2 2018 | share | Decrease | -18.83% | -10.1K shares | -171K | $98.24 | 43.55K |
| Q1 2018 | share | Decrease | -1.56% | -850 shares | 220K | $82.93 | 53.65K |
| Q4 2017 | share | Decrease | -2.68% | -1.5K shares | 797K | $77.59 | 54.5K |
| Q3 2017 | share | Increase | +19.15% | 9K shares | 1.27M | $61.28 | 56K |
| Q2 2017 | share | Decrease | -30.88% | -21K shares | -782K | $46 | 47K |
| Q1 2017 | share | Decrease | -9.33% | -7K shares | 42K | $43.3 | 68K |
| Q4 2016 | share | Increase | +29.31% | 17K shares | -35K | $38.7 | 75K |
| Q3 2016 | share | 0.00% | 0 shares | 301K | $50.64 | 58K | |
| Q2 2016 | share | Decrease | -10.77% | -7K shares | 65K | $45.45 | 58K |
| Q1 2016 | share | Increase | 0.00% | 65K shares | 2.57M | $39.55 | 65K |